Taking metformin for type 2 diabetes is not associated with a greater risk of COVID-19 or COVID-19 mortality, according to new findings published in the Journal of Clinical Endocrinology and Metabolism.
Metformin is often prescribed as a first-line therapy for type 2 diabetes and has been linked to beneficial outcomes for a number of other health issues. Considering how many patients are on metformin, the authors wrote, there is “an urgent need” to clarify its potential impact as the pandemic continues to claim lives all over the world.
The research team examined a massive dataset of type 2 diabetes patients from the U.K. The cohort included more than 29,000 patients actively taking metformin and other glucose-lowering agents as well as more than 10,000 patients on glucose-lowering agents, but not metformin.
Overall, the team found no connection between taking metformin for type 2 diabetes and the risk of COVID-19, COVID-19 mortality or all-cause mortality.
"type" - Google News
February 20, 2021 at 03:45AM
https://ift.tt/3dvCacY
Taking metformin for type 2 diabetes does not increase a patient's COVID-19 risk - Cardiovascular Business
"type" - Google News
https://ift.tt/2WhN8Zg
https://ift.tt/2YrjQdq
Bagikan Berita Ini
0 Response to "Taking metformin for type 2 diabetes does not increase a patient's COVID-19 risk - Cardiovascular Business"
Post a Comment